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p53 overexpression was equally often recorded in luminal B
and Her2+ subtypes of BC and slightly less frequently in
triple-negative subtype. Accumulation of p53 was 2 times less fre-
quently detected in luminal A subtype in comparison with triple -
negative cancer and 2.5 and 2.7 times less frequently in compar-
ison with luminal B and Her2+ BC, respectively. Study of bcl-2
expression showed reducing the frequency of positive tumor cell
staining in dependence on the receptor status of tumor: positive
cases were several times less frequent in triple-negative and
Her2+ subtypes in comparison with luminal A and B subtypes.
Luminal A subtype was characterized by the minimal p53,
topoisomerase 2a and androgen receptor expression and maxi-
mal expression of bcl-2 and E-cadherin. Luminal B subtype
showed a high expression of p53, bcl-2 and androgen receptors
and moderate expression of topoisomerase 2a and E-cadherin.
High expression of topoisomerase 2a, low expression of androgen
receptors and moderate expression of E- cadherin were registered
in triple-negative BC. The maximal expression of topoisomerase
2a and p53, as well as low expression of bcl-2 and E-cadherin,
was observed in Her2+ subtype.
Conclusions: CD8+ T-lymphocytes dominate in tumor tissue of
BC. Besides, tumor tissue of luminal A BC contains more NK-cells
than other subtypes. A number of differences in expression of
apoptosis-controlling proteins was observed in various molecular
subtypes of breast cancer. Luminal A BC was noted for the mini-
mal p53 expression and maximal bcl-2expression. Luminal B sub-
type had a high p53 and bcl- 2 expression. In Her2+ BC p53
expression was maximal and bcl-2 expression was low. The
described differences allow assessing molecular subtypes of
breast cancer and predicting the disease course from previously
unexplored perspectives.
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Background: Women’s reproductive health is significantly
determined by the relative constancy of the vaginal microbiota
(Ravel et al., 2011). Change of its qualitative and quantitative
composition is regarded as an edge with pathology of the condi-
tion with extremely diverse effects: from decreasing the quality
of life to enhancing the carcinogenic risks induced by anaerobic
bacteria metabolites (Mavzyutov et al., 2007). It was shown that
vaginal microbiota changes typical for bacterial vaginosis (BV)
are accompanied by similar changes in the CC microbiota (Smith
et al., 2014) that is associatedwith an increased risk of HIV, herpes
virus type 2, HPV, and neoplasia contamination (Borgdorff et al.,
2014).
Purpose of the study: To identify the bacteria types that influ-
ence the most significant changes in cytological patterns of the
CC in women with BV.
Materials and methods: To identify cytological characteristics
of the inflammatory process in the CC associated with BV and
quantitative species-specific changes in cervical microbiota,
cervical scrapings of 122 women (aged 18–45) were studied with
LC (Krjukova, 2008) and real-time PCR (‘‘Femoflor 16”, Russia).
Results: Following the cytological characteristics of the cellular
composition (abs.), presence of columnar epithelium, state of cell
nuclei, nuclear size, chromatin state, number of nuclei in the cell
(abs.Val.), existence and nature of nuclear changes, changes of the
cell shape, vacuolization of cytoplasm, cytoplasm clearing, cell
cytolysis, signs of keratinization, changes of cell size, increased
nuclear-cytoplasmic ratio and other factors, the women were
divided into 2 groups. The first group consisted of women with
cervicitis without vaginosis, and the other group- with cervicitis
associated with BV. Quantitative molecular genetic studies have
shown that in the cervicitis associated with BV, significantly
higher values were characterized by total bacterial mass and the
scraping content of Gardnerella vaginalis/Prevotella bivia/Porphy-
romonas spp., Sneathia spp./Leptotrihia spp./Fusobacterium spp.,
Megasphaera spp./Veillonella spp./Dialister spp., Mobiluncus
spp./Corynebacterium spp., Lachnobacterium spp./Clostridium spp.,
Peptostreptococcus spp., Atopobium vaginae and Ureaplasma spp.
However, the concentration of Enterobacteriaceae and Myco-
plasma hominis in cervicitis not accompanied and not associated
with BVwas not significantly different. According to LC, in cervici-
tis associated with BV, the test material contained statistically
significant (p < 0.05) large quantities of surface epithelial cells,
leukocytes, macrophages, ‘‘key” cells and small rod-shaped bacte-
ria, but cytolysis and ectomorphy bacteria were not found.
According to factor analysis of quantitative PCR and LC, the most
significant was positive relationship between increasing concen-
tration of Lachnobacterium spp./Clostridium spp., Mobiluncus spp./
Corynebacterium spp., Peptostreptococcus spp.,A. vaginae Mycoplasma
hominis and detection of small rod-shaped bacterial flora and the
‘‘key” cells; and negative – with the identification of accommoda-
tion bacteria. The increase of Ureaplasma spp. in the cervical
scraping in connection with BV was accompanied by increase of
cells without increase of macrophages. The combined increase
of leukocytes and macrophages was accompanied by a significant
reduction of surface epithelium cells.
Conclusion: 1. Cytological pattern of inflammation during BV
differs from the pattern of cervical inflammation not associated
with BV; 2. Quantitative changes of the CC microbiota in BV
detected by PCR are correlated with the cytological features of
the inflammation pattern; 3. The influence of inflammation
caused by quantitative changes in the CC microbiota on the
increased risk of neoplastic processes is not excluded.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.073
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Matrix metalloproteinases (MMPs) – zinc containing endopep-
tidases which cleave the different components of the extracellu-
lar matrix. However, not all biological mechanisms and the
effects of these endopeptidases are well-established. Previously
it was believed that MMP functions only as proteolytic enzymes,
but it was found later that MMPs could act as regulators of protein
kinase signal transduction pathways by modifying receptors and
signaling molecules.
One of the most important substrates for MMP is transforming
growth factor-b (TGF-bÞ, which is a receptor for the ligand TGF-b-
signal transduction pathway comprises a network of protein
kinase pathways responsible for many of the processes of tumor
progression, including epithelial mesenchymal transformation
(EMT). Despite the fact that melanoma cells are not of epithelial
origin, they express the epithelial E-cadherin that is necessary
for their interaction with the basal layers of the epidermis. The
degradation of the extracellular matrix and loss of expression of
E-cadherin are major changes needed to start the processes of
melanoma invasion. One of the markers of EMT is a transcription
factor twist1. Twist1 activates the processes of epithelial-
mesenchymal transformation and increases the invasion of mel-
anoma cells by increasing transcription of MMP. The aim of this
study was to evaluate expression levels TGF-b, twist1 under selec-
tive inhibition of MMP-9 and combined inhibition of MMP-9 and-
13 in melanoma model in vivo; to determine the role of MMPs as
possible regulators of TGF-b-way signal transduction, as well as
associated with TGF-b EMT process.
The study was approved by the local Ethic Committee (proto-
col No. 144/ 2012 of 15.11.2012). Melanoma B16-bearing mice (con-
trol group consisted of 7 animals, MMP-9 inhibitor treatment
group – 7, MMP-9/13 inhibitor treatment group – 7 animals) under-
went experimental treatment by MMP inhibitor (Calbiochem,
USA) by daily application within 7 days. Control group consisted
of animals without treatment. Efficacy of MMP-9 inhibition was
evaluated by gelatinize zymography. TGF-b1 and twist 1 tran-
scription factor expression was determined by PCR real-time
using StepOne System (Applied Biosystems, USA). Statistical
analysis was done by Kruskal–Wallis test and Multiple Compar-
isons. The P values lower 0.05 were considered as significant.
It was found that the selective inhibition of MMP-9 did not
induce changes in expression levels of TGF-b and twist1, however,
the combined inhibition of MMP-9 and MMP-13 significantly
reduced the expression levels of the transcription factor twist1
and TGF-b. The results show that MMP-9 and MMP-13 act as acti-
vators of TGF-b-signal transduction pathway and could be consid-
ered as potential molecular targets for experimental therapy for
cancer.
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In 2004, COP1 was characterized as p53 E3-specific human
ubiquitin ligase according to in vitro studies. Later, oncogenic
activity of COP1 and correlation of its overexpression with level
of p53 protein in clinical tumor samples and cell lines were
shown. High expression level of COP1 was described in 25 of 32
cases of breast carcinomas and in 76 out of 171 cases of ovarian
carcinomas. High expression level of COP1 was described in hep-
atocellular carcinoma cell lines (PLC, Hep3B and HepG2, Huh7). In
40 of 55 cases of pancreatic cancer, overexpression of COP1 was
also noted. Some types of leukemia, melanoma, breast, lung
and prostate cancer contain focal deletions of COP1. COP1 overex-
pression was also found in non- oncological diseases like
Duchenne muscular dystrophy, ischemic cardiomyopathy and
juvenile dermatomyositis.
Similar to other p53-related E3 -ubiquitin ligases COP1 has dif-
ferent substrates. The selection of target for ubiquitination
depends on cell type or differentiation stage. Among the sub-
strates of COP1, besides p53 are: c-Jun, ETV1, ACC, TORC2, FOXO1
and C/EBPa, FIP200.
To identify novel proteins that interact with COP1 we applied
proteomics. Proteins co-immunoprecipitated with COP1 were
analyzed by MALDI -TOF mass spectrometry. To achieve this,
COP1–3xFlag expression vector was generated and transfected
into HEK 293T cells by calcium phosphate transfection method.
Protein complexes were immunoprecipitated with anti-FLAG
beads. Bound proteins were then separated by 1D SDS–PAGE gel
electrophoresis and analyzed by means of ESI-LC/MS/MS mass
spectrometry. Subsequent bioinformatics analysis of the interact-
ing proteins was employed. About 25% of identified proteins were
attributed to the cytoskeleton proteins, almost 20% of proteins
had known role in metabolism. According to the literature data,
it was not surprising to find several proteins involved in the lipid
metabolism. Finally, a significant groups of interactants play role
in transcription, cell adhesion, apoptosis, protein modification
and transport. It is important to note that several COP1-bound
proteins can be strong regulators of cell cycle in G2/M transition.
Our data can be used for the subsequent studies of previously
unknown roles of COP1 in different diseases.
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